Clinical Trial Update: A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a demethylation drug combined with chemotherapy in intermediate-risk acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Xuejie Jiang | Conditions: Leukemia, Myeloid | Phase 2 | Status: UNKNOWN